110 related articles for article (PubMed ID: 12564938)
1. Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.
Qu Q; Chu JW; Sharom FJ
Biochemistry; 2003 Feb; 42(5):1345-53. PubMed ID: 12564938
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.
Sauna ZE; Ambudkar SV
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2515-20. PubMed ID: 10716986
[TBL] [Abstract][Full Text] [Related]
4. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
[TBL] [Abstract][Full Text] [Related]
5. Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.
Russell PL; Sharom FJ
Biochem J; 2006 Oct; 399(2):315-23. PubMed ID: 16803457
[TBL] [Abstract][Full Text] [Related]
6. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
7. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
8. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.
Qu Q; Sharom FJ
Biochemistry; 2002 Apr; 41(14):4744-52. PubMed ID: 11926837
[TBL] [Abstract][Full Text] [Related]
9. Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.
Lu P; Liu R; Sharom FJ
Eur J Biochem; 2001 Mar; 268(6):1687-97. PubMed ID: 11248688
[TBL] [Abstract][Full Text] [Related]
10. Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates.
Kerr KM; Sauna ZE; Ambudkar SV
J Biol Chem; 2001 Mar; 276(12):8657-64. PubMed ID: 11121420
[TBL] [Abstract][Full Text] [Related]
11. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
12. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
13. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
Rao US
Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
[TBL] [Abstract][Full Text] [Related]
14. Catalytic mechanism of P-glycoprotein.
Senior AE
Acta Physiol Scand Suppl; 1998 Aug; 643():213-8. PubMed ID: 9789563
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of ATP-dependent multidrug transport by P-glycoprotein.
Shapiro AB; Ling V
Acta Physiol Scand Suppl; 1998 Aug; 643():227-34. PubMed ID: 9789565
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
Maki N; Moitra K; Ghosh P; Dey S
J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
[TBL] [Abstract][Full Text] [Related]
17. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
Martin C; Higgins CF; Callaghan R
Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
[TBL] [Abstract][Full Text] [Related]
18. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.
Taylor AM; Storm J; Soceneantu L; Linton KJ; Gabriel M; Martin C; Woodhouse J; Blott E; Higgins CF; Callaghan R
Br J Pharmacol; 2001 Dec; 134(8):1609-18. PubMed ID: 11739236
[TBL] [Abstract][Full Text] [Related]
19. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
Sauna ZE; Smith MM; Muller M; Ambudkar SV
J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
Liu R; Sharom FJ
Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]